In particular, PERK-driven Nrf2 activation runs regeneration of intracellular antioxidants, neutralization of ROS, defense from oxidative DNA damage, cell cycle checkpoint inhibition, and significant improvement of tumor growth (Luo and Lee, 2013). Here, EIF2AK3 is linked to neoplasm.